18-04-2025 18:08 via drugs.com

Midafternoon Dosing Improves Lung Function in Atopic Asthma

FRIDAY, April 18, 2025-- Midafternoon dosing with beclomethasone dipropionate is associated with better clinical outcomes in mild-to-moderate atopic asthma, according to a study published online April 15 in Thorax.Ran Wang, Ph.D., from the NIHR...
Read more ยป

Pharmaceutical Industry news



Withdrawal of Flovent Led to Discontinuation of Inhaled Steroids for Children With Asthma
Advanced Biological Age Linked to Increased Risk for Incident Dementia
Gluten-Free Diet for Celiac Disease Increases Arsenic Exposure in Children
Urinary Incontinence Linked to CVD Risk Factors, Comorbid Conditions
No Benefit Seen for Revascularization Added to Drug Therapy in Carotid Stenosis
Buprenorphine for Opioid Use Disorder in Pregnancy Can Improve Outcomes
Semaglutide Beneficial in Metabolic Dysfunction-Associated Steatohepatitis, Fibrosis
Exposure to Smoke Pollution Ups Risk for Hospitalization for Respiratory Disease
Estimated 7.2 Million Americans 65 Years and Older Have Alzheimer Dementia
Prior Military Sexual Trauma Linked to Late-Life Suicide Attempt
Study IDs Nonclinical, Modifiable Risk Factors Tied to Sudden Cardiac Arrest
Risk Factors for Alzheimer Disease Linked to Cognitive Function Before Midlife
Peanut Oral Immunotherapy Efficacious in Allergic Adults
Metformin Beneficial for Osteoarthritis Knee Pain in Overweight, Obesity
Desktop versie